CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 114 filers reported holding CULLINAN ONCOLOGY INC in Q1 2024. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $779,665 | +78.3% | 45,755 | +6.7% | 0.00% | – |
| Q4 2023 | $437,171 | +148.0% | 42,902 | +120.2% | 0.00% | – |
| Q3 2023 | $176,285 | -18.5% | 19,479 | -3.1% | 0.00% | – |
| Q2 2023 | $216,362 | +96.7% | 20,108 | +87.1% | 0.00% | – |
| Q1 2023 | $109,973 | -3.0% | 10,750 | +0.0% | 0.00% | – |
| Q4 2022 | $113,381 | -16.0% | 10,747 | +1.7% | 0.00% | – |
| Q3 2022 | $135,000 | +0.7% | 10,563 | +1.4% | 0.00% | – |
| Q2 2022 | $134,000 | +2.3% | 10,419 | -15.9% | 0.00% | – |
| Q1 2022 | $131,000 | -35.8% | 12,389 | -6.1% | 0.00% | – |
| Q4 2021 | $204,000 | -5.1% | 13,187 | +38.3% | 0.00% | – |
| Q3 2021 | $215,000 | -7.7% | 9,534 | +5.6% | 0.00% | – |
| Q2 2021 | $233,000 | – | 9,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |